Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-11-23
DOI
10.3389/fimmu.2020.606456
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human genetics of life-threatening influenza pneumonitis
- (2020) Qian Zhang HUMAN GENETICS
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
- (2020) Carly G.K. Ziegler et al. CELL
- Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients
- (2020) Pierre Bost et al. CELL
- Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
- (2020) Zhuo Zhou et al. Cell Host & Microbe
- Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19
- (2020) Hin Chu et al. CLINICAL INFECTIOUS DISEASES
- Gene Expression Regulation of the Type I Interferon‐Induced Protein Schlafen 11
- (2020) Andre Raymundo Borrego et al. FASEB JOURNAL
- The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients
- (2020) Jing Yuan et al. INFLAMMATION RESEARCH
- Type I Interferons Act Directly on Nociceptors to Produce Pain Sensitization: Implications for Viral Infection-Induced Pain
- (2020) Paulino Barragán-Iglesias et al. JOURNAL OF NEUROSCIENCE
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- IFN-κ suppresses the replication of influenza A viruses through the IFNAR-MAPK-Fos-CHD6 axis
- (2020) Yongquan He et al. Science Signaling
- Human Type I Interferon Antiviral Effects in Respiratory and Reemerging Viral Infections
- (2020) Patricio L. Acosta et al. Journal of Immunology Research
- Feature selection based on differentially correlated gene pairs reveals the mechanism of IFN-β therapy for multiple sclerosis
- (2020) Tao Jin et al. PeerJ
- Antiviral activities of type I interferons to SARS-CoV-2 infection
- (2020) Emily Mantlo et al. ANTIVIRAL RESEARCH
- Type 1 interferons as a potential treatment against COVID-19
- (2020) Erwan Sallard et al. ANTIVIRAL RESEARCH
- Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients
- (2020) Nan Wang et al. Cell Host & Microbe
- Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases
- (2020) Jiao Jiang et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
- (2020) Benjamin Israelow et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Role of Type I IFNs in Influenza: Antiviral Superheroes or Immunopathogenic Villains?
- (2020) Wenxin Wu et al. Journal of Innate Immunity
- A pivotal role for Interferon-α receptor-1 in neuronal injury induced by HIV-1
- (2020) Hina Singh et al. Journal of Neuroinflammation
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial
- (2020) Seyed Sina Naghibi Irvani et al. Trials
- Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ
- (2020) Kirsty E. Waddington et al. Frontiers in Immunology
- Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19
- (2020) Jeong Seok Lee et al. Science Immunology
- Evaluation of safety, efficacy, tolerability, and treatment-related outcomes of type I interferons for human coronaviruses (HCoVs) infection in clinical practice: An updated critical systematic review and meta-analysis
- (2020) Chengjun Yu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Therapeutic Effectiveness of Interferon-α2b Against COVID-19: The Cuban Experience
- (2020) Ricardo Pereda et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- The Dynamic Interface of Viruses with STATs
- (2020) Angela R. Harrison et al. JOURNAL OF VIROLOGY
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
- (2020) Jin-Yan Li et al. VIRUS RESEARCH
- Sustained Type I Interferon Reinforces NK Cell–Mediated Cancer Immunosurveillance during Chronic Virus Infection
- (2019) Ji Hoon Oh et al. Cancer Immunology Research
- Elastic net-based prediction of IFN-β treatment response of patients with multiple sclerosis using time series microarray gene expression profiles
- (2019) Arika Fukushima et al. Scientific Reports
- Interferons α and β in cancer: therapeutic opportunities from new insights
- (2019) Ernest C. Borden NATURE REVIEWS DRUG DISCOVERY
- A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma
- (2019) Lorena P. Suarez-Kelly et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Schlafen 11 Restricts Flavivirus Replication.
- (2019) Federico Valdez et al. JOURNAL OF VIROLOGY
- Type I interferon signaling, regulation and gene stimulation in chronic virus infection
- (2019) Sabelo Lukhele et al. SEMINARS IN IMMUNOLOGY
- Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date
- (2019) Renaud Felten et al. Drug Design Development and Therapy
- Pathogenic Role of Type I Interferons in HIV-Induced Immune Impairments in Humanized Mice
- (2019) Lishan Su Current HIV/AIDS Reports
- Conditional Upregulation of IFN-α Alone Is Sufficient to Induce Systemic Lupus Erythematosus
- (2019) Chieri Akiyama et al. JOURNAL OF IMMUNOLOGY
- CRISPR/Cas9-based Knockout Strategy Elucidates Components Essential for Type 1 Interferon Signaling in Human HeLa Cells
- (2019) Victoria Urin et al. JOURNAL OF MOLECULAR BIOLOGY
- Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes
- (2019) Chunwan Lu et al. Journal for ImmunoTherapy of Cancer
- STAT3 phosphorylation mediates the stimulatory effects of interferon alpha on B cell differentiation and activation in SLE
- (2019) Aurélie De Groof et al. RHEUMATOLOGY
- Have Cells Harboring the HIV Reservoir Been Immunoedited?
- (2019) Szu-Han Huang et al. Frontiers in Immunology
- Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells
- (2019) Nobuhiro Tsuchiya et al. Cell Reports
- USP18 is a significant driver of memory CD4 T-cell reduced viability caused by type I IFN signaling during primary HIV-1 infection
- (2019) Xavier Dagenais-Lussier et al. PLoS Pathogens
- Photodynamic Modulation of Type 1 Interferon Pathway on Melanoma Cells Promotes Dendritic Cell Activation
- (2019) María Julia Lamberti et al. Frontiers in Immunology
- IFN-α kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study
- (2019) Frederic A Houssiau et al. ANNALS OF THE RHEUMATIC DISEASES
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Monotonically Differentially Expressed Genes for IFN-β-Treated Multiple Sclerosis Patients
- (2019) Suyan Tian et al. Biomed Research International
- Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance
- (2018) Zhenqing Ye et al. CLINICAL CANCER RESEARCH
- Aberrant cell signalling in PBMCs upon IFN-α stimulation in primary Sjögren's syndrome patients associates with type I interferon signature
- (2018) Richard Davies et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Type I interferon in rheumatic diseases
- (2018) Theresa L. Wampler Muskardin et al. Nature Reviews Rheumatology
- Interferon alpha: The key trigger of type 1 diabetes
- (2018) Angela Lombardi et al. JOURNAL OF AUTOIMMUNITY
- Interferon-α Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling
- (2018) Alexandr V. Bazhin et al. Frontiers in Immunology
- HIV blocks Type I IFN signaling through disruption of STAT1 phosphorylation
- (2018) Nam V Nguyen et al. Innate Immunity
- Sirtuin 2–mediated deacetylation of cyclin-dependent kinase 9 promotes STAT1 signaling in type I interferon responses
- (2018) Ewa M. Kosciuczuk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of TPL2 by interferon-α suppresses bladder cancer through activation of PDE4D
- (2018) Zhe Qiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- IFNα Impairs Autophagic Degradation of mtDNA Promoting Autoreactivity of SLE Monocytes in a STING-Dependent Fashion
- (2018) Katerina Gkirtzimanaki et al. Cell Reports
- Schlafen 14 (SLFN14) is a novel antiviral factor involved in the control of viral replication
- (2017) Rak-Kyun Seong et al. IMMUNOBIOLOGY
- Interferon alpha impairs insulin production in human beta cells via endoplasmic reticulum stress
- (2017) Angela Lombardi et al. JOURNAL OF AUTOIMMUNITY
- Elevated sodium chloride drives type I interferon signaling in macrophages and increases antiviral resistance
- (2017) Wu-Chang Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The molecular basis for differential type I interferon signaling
- (2017) Gideon Schreiber JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone H1 depletion triggers an interferon response in cancer cells via activation of heterochromatic repeats
- (2017) Andrea Izquierdo-Bouldstridge et al. NUCLEIC ACIDS RESEARCH
- Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma
- (2017) A D Arslan et al. ONCOGENE
- Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-α signaling
- (2017) Brett S. Marro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
- (2017) Meredith L. Stone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen–specific CTLs
- (2017) Michael C. Brown et al. Science Translational Medicine
- Dietary quercetin potentiates the antiproliferative effect of interferon-α in hepatocellular carcinoma cells through activation of JAK/STAT pathway signaling by inhibition of SHP2 phosphatase
- (2017) Ighodaro Igbe et al. Oncotarget
- CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response
- (2017) Abdul S. Qadir et al. Cell Reports
- Enhanced Inflammasome Activity in Systemic Lupus Erythematosus Is Mediated via Type I Interferon-Induced Up-Regulation of Interferon Regulatory Factor 1
- (2017) Jianhua Liu et al. Arthritis & Rheumatology
- Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism
- (2017) Yuchen Nan et al. Frontiers in Immunology
- Canonical and Non-Canonical Aspects of JAK–STAT Signaling: Lessons from Interferons for Cytokine Responses
- (2017) Andrea Majoros et al. Frontiers in Immunology
- Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß
- (2017) Isaac Hurtado-Guerrero et al. PLoS One
- AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies
- (2016) Steffen Meyer et al. CELL
- A novel anti-viral role for STAT3 in IFN-α signalling responses
- (2016) Rebecca Mahony et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs
- (2016) Liang Cheng et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting type I interferon–mediated activation restores immune function in chronic HIV infection
- (2016) Anjie Zhen et al. JOURNAL OF CLINICAL INVESTIGATION
- Central Role of ULK1 in Type I Interferon Signaling
- (2015) Diana Saleiro et al. Cell Reports
- Pathogenic Influenza Viruses and Coronaviruses Utilize Similar and Contrasting Approaches To Control Interferon-Stimulated Gene Responses
- (2014) V. D. Menachery et al. mBio
- Inhibition of p38 Mitogen-activated Protein Kinase Impairs Influenza Virus-induced Primary and Secondary Host Gene Responses and Protects Mice from Lethal H5N1 Infection
- (2013) Yvonne Börgeling et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Schlafen Family of Proteins and Their Regulation by Interferons
- (2013) Evangelos Mavrommatis et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Immunoregulatory Effects of Interferon-β in Suppression of Th17 cells
- (2013) Leesa M. Pennell et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression
- (2012) Zana Brkic et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon
- (2012) Allison L Totura et al. Current Opinion in Virology
- Binding and activity of all human alpha interferon subtypes
- (2011) Thomas B. Lavoie et al. CYTOKINE
- The role of cell type-specific responses in IFN- therapy of multiple sclerosis
- (2011) J. A. Zula et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interferon-β is a key regulator of proinflammatory events in experimental autoimmune encephalomyelitis
- (2010) CL Galligan et al. Multiple Sclerosis Journal
- Wnt signal transduction pathways
- (2010) Yuko Komiya et al. Organogenesis
- Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF- B Signaling
- (2009) M. Frieman et al. JOURNAL OF VIROLOGY
- Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
- (2007) R. E. Randall et al. JOURNAL OF GENERAL VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now